References
- Distiller LA. Portable insulin infusion pumps as an alternative means of insulin delivery in type I diabetic patients. S Afr Med J. 1983; 63 (13): 475–479.
- Bonnici F. Have insulin pumps fulfilled their expectations? Diabetographia. 1990; 12(2): 38.
- Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years. Evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care. 2002; 25(3): 593–598.
- Continuous subcutaneous insulin infusion for the treatment of diabetes. NICE [homepage on the Internet]. Available from: http://www.nice.org.uk
- Van Bon AC, Bode BW, Sert-Langeron C, et al. Insuline glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial. Diabetes Technol Ther. 2011; 13(6); 607–614.
- Hayat H, Carling J, Dudley S, et al. Benefits of pump therapy in diabetic pregnancy. Diabetic Med. 2005; 22(Suppl 2:279.
- McMahon SK, Airey FL, Marangou DA, et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabetic Med. 2005; 22(1): 92–96.
- Brown VJ. An overview of insulin pump therapy: appropriate use of an expensive resource. JEMDSA. 2012; 17(3): 122–126.